Eurofins strengthens its leadership in seed and plant testing with the acquisition of BioDiagnostics, Inc.

Eurofins Scientific (EUFI.PA), the global leader in analytical support to the global agri-food and feed market, announces the acquisition of BioDiagnostics Inc. (BDI), one of the leading seed and plant-tissue testing laboratories serving the agricultural industry in the US.

Founded in 1996, BDI employs 120 staff at its laboratory in River Falls, WI. BDI offers genetic, seed quality, as well as analytical chemistry testing services to the seed and plant industries. The company has developed a strong competence in DNA analysis of field crops, especially for corn and soybeans. BDI's competencies complement and build onto the recognized capabilities that Eurofins provides to the seed and agricultural industry, and enhances the Group's ability to provide the broadest range of analytical services, including the latest innovations in genomics technologies for seed and crop breeding, to support the agri-food and feed market.

The addition of BDI into Eurofins' growing footprint in food and agricultural testing in the US demonstrates the Group's commitment in the domestic market. BDI's capabilities, as well as its geographical market, perfectly complement Eurofins' existing footprint. In return, BDI will gain access to the latest technologies in genetic testing and other analytical methods, as well as all of the Group's technical know-how.

Comment fromQuentin Schultz, President BDI: "We are excited to become a part of the Eurofins group. We share the same values and the same commitment to providing the highest quality of analytical services. Our clients can continue to expect the same quality of service that they have come to associate with BDI, and should benefit from the broader range of capabilities that we will be able to offer as part of an international laboratory network."

Comment fromDr. Gilles Martin, Eurofins CEO: "We are pleased to welcome BDI to the Eurofins Group. BDI is an excellent strategic fit to Eurofins' footprint in the seed and plant testing market, and we look forward to further strengthening their market position by offering the full range of capabilities of the Eurofins Group".

For more information about Eurofins, please visit www.eurofins.com or contact:

Notes for the editor:

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.

With over 17,000 staff in more than 200 laboratories across 36 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.